dermveda ULTRA HEMORRHOID AND FISSURE

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: dermveda ULTRA HEMORRHOID AND FISSURE
Generic name: SULFUR, CURCUMA LONGA
Manufacturer: Celcius Corp.
Product type: HUMAN OTC DRUG
SPL set ID: 044e0503-215b-4d57-96d9-62a54a8de4d1
SPL ID: 304ebcc3-da32-48b6-bc8a-be557dd0c6ce
Version: 1
Effective date: 2026-08-10
Source export date: 2026-09-28
Source partition: 4
Source file: https://download.open.fda.gov/drug/label/drug-label-0004-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/c7ca0b7091cdaeab3f27713a6eef00adcf8fe722383633ddce61531b4c840544/drug-label-0004-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:26:46

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 10 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		dermveda ULTRA HEMORRHOID AND FISSURE	openfda.brand_name
generic name		SULFUR, CURCUMA LONGA	openfda.generic_name
manufacturer name		Celcius Corp.	openfda.manufacturer_name
ndc	package	83819-383-02	openfda.package_ndc
ndc	product	83819-383	openfda.product_ndc
ndc11	package	83819038302	derived:openfda.package_ndc
spl id		304ebcc3-da32-48b6-bc8a-be557dd0c6ce	id
spl set id		044e0503-215b-4d57-96d9-62a54a8de4d1	set_id
unii		856YO1Z64F	openfda.unii
unii		70FD1KFU70	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only . Product is not FDA evaluated and will not cure Herpes, will not prevent future outbreaks and will not stop the spread of Herpes virus. When using this product • Apply the product exclusively to affected areas. • Avoid application near or around the eyes. • Do not share this product with others to mitigate the risk of infection or viral transmission. Stop use and ask a doctor if • If symptoms persist or inflammation increases after weeks of use or if the itch increases. • Increase in redness on skin. Pregnant or Breast Feeding • Ask a Health Professional before use. Keep out of reach of children . If swallowed, get medical help or contact a poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.